Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.

Schairer C, McCarty CA, Isaacs C, Sue LY, Pollak MN, Berg CD, Ziegler RG.

Horm Cancer. 2010 Apr;1(2):100-11. doi: 10.1007/s12672-010-0013-y.

PMID:
21761353
2.

Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones.

Key TJ, Appleby PN, Allen NE, Reeves GK.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):960-5. doi: 10.1158/1055-9965.EPI-10-0061. Epub 2010 Mar 16. Review.

3.

Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample.

Völzke H, Nauck M, Rettig R, Dörr M, Higham C, Brabant G, Wallaschofski H.

Eur J Endocrinol. 2009 Nov;161(5):705-13. doi: 10.1530/EJE-09-0374. Epub 2009 Aug 18.

4.

The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.

Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad K, Grønbaek H, Tjønneland A, Halkjaer J, Dossus L, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Boutron-Ruault MC, De Lauzon B, Clavel-Chapelon F, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Vrieling A, van Gils CH, Peeters PH, Gram IT, Skeie G, Lund E, Rodríguez L, Jakszyn P, Molina-Montes E, Tormo MJ, Barricarte A, Larrañaga N, Khaw KT, Bingham S, Rinaldi S, Slimani N, Norat T, Gallo V, Riboli E, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1333-40. doi: 10.1158/1055-9965.EPI-08-0781.

5.

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD.

J Natl Cancer Inst. 2009 Jan 7;101(1):48-60. doi: 10.1093/jnci/djn415. Epub 2008 Dec 30.

6.

IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

Perks CM, Holly JM.

J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):455-69. doi: 10.1007/s10911-008-9106-4. Epub 2008 Nov 25. Review.

PMID:
19031049
7.

Insulin and insulin-like growth factor signalling in neoplasia.

Pollak M.

Nat Rev Cancer. 2008 Dec;8(12):915-28. doi: 10.1038/nrc2536. Review. Erratum in: Nat Rev Cancer. 2009 Mar;9(3):224.

PMID:
19029956
8.

Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.

Vatten LJ, Holly JM, Gunnell D, Tretli S.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2097-100. doi: 10.1158/1055-9965.EPI-08-0212.

9.

Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays.

Brugts MP, Ranke MB, Hofland LJ, van der Wansem K, Weber K, Frystyk J, Lamberts SW, Janssen JA.

J Clin Endocrinol Metab. 2008 Jul;93(7):2539-45. doi: 10.1210/jc.2007-2454. Epub 2008 Apr 8.

PMID:
18397983
10.

Body shape throughout life and correlations with IGFs and GH.

Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE.

Endocr Relat Cancer. 2007 Sep;14(3):721-32. Erratum in: Endocr Relat Cancer. 2008 Mar;15(1):365.

11.

Normal levels of serum IGF-I: determinants and validity of current reference ranges.

Brabant G, Wallaschofski H.

Pituitary. 2007;10(2):129-33. Review.

PMID:
17487588
12.

Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.

Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):763-8.

13.

Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.

Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ.

J Endocrinol. 2006 Dec;191(3):605-12.

14.

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

PMID:
17018787
15.

The role of the IGF system in cancer growth and metastasis: overview and recent insights.

Samani AA, Yakar S, LeRoith D, Brodt P.

Endocr Rev. 2007 Feb;28(1):20-47. Epub 2006 Aug 24. Review.

PMID:
16931767
16.

IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).

Rinaldi S, Peeters PH, Berrino F, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Téhard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Trichopoulou A, Trichopoulos D, Koliva M, Palli D, Panico S, Tumino R, Sacerdote C, van Gils CH, van Noord P, Grobbee DE, Bueno-de-Mesquita HB, Gonzalez CA, Agudo A, Chirlaque MD, Barricarte A, Larrañaga N, Quiros JR, Bingham S, Khaw KT, Key T, Allen NE, Lukanova A, Slimani N, Saracci R, Riboli E, Kaaks R.

Endocr Relat Cancer. 2006 Jun;13(2):593-605.

17.

Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.

Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.

Endocr Relat Cancer. 2006 Jun;13(2):583-92.

18.

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.

Renehan AG, Harvie M, Howell A.

Endocr Relat Cancer. 2006 Jun;13(2):273-8. Review.

19.

Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.

Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):972-8.

20.

Are mammotropic hormones mainly permissive for the development of breast cancer?

Trichopoulos D, Bamia C, Lagiou P, Trichopoulou A.

Int J Cancer. 2006 Jun 1;118(11):2863-5.

Supplemental Content

Support Center